Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
Structure-guided drug discovery emerged in the 1970s and 1980s, stimulated by the three-dimensional structures of protein targets that became available, mainly through X-ray crystal structure analysis, assisted by the development of synchrotron radiation sources. Structures of known drugs or inhibit...
Κύριοι συγγραφείς: | Thomas, SE, Collins, P, James, RH, Mendes, V, Charoensutthivarakul, S, Radoux, C, Abell, C, Coyne, AG, Floto, RA, Von Delft, F, Blundell, TL |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Royal Society
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Fragment hotspot mapping to identify selectivity-determining regions between related proteins
ανά: Smilova, MD, κ.ά.
Έκδοση: (2022) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
ανά: Sheikh Mohammed Arif, κ.ά.
Έκδοση: (2022-03-01) -
Hotspots API: a python package for the detection of small molecule binding hotspots and application to structure-based drug design
ανά: Curran, PR, κ.ά.
Έκδοση: (2020) -
The luminous X-ray hotspot in 4C 74.26: synchrotron or inverse-Compton
emission?
ανά: Erlund, M, κ.ά.
Έκδοση: (2007) -
Evidence that the maximum electron energy in hotspots of FR II galaxies is not determined by synchrotron cooling
ανά: Araudo, A, κ.ά.
Έκδοση: (2016)